Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Merck
CRO
Merck to use N-Power clinical trial platform for cancer studies
Merck is partnering with N-Power Medicine, using the new company's platform for cancer clinical trials and leading a recently closed series B.
Helen Floersh
Jul 1, 2024 4:20pm
Merck compares pneumococcal vaccine to 1983 warhorse
Apr 29, 2024 9:00am
Merck inks R&D deal with Intermountain spinoff Culmination Bio
Jan 25, 2024 9:30am
Merck seals $610M deal to acquire preclinical biotech Caraway
Nov 21, 2023 8:09am
ASCO: Astellas exec adds gray hair with 3 pending drug approvals
Jun 7, 2023 10:50am
Organon builds pipeline for women's health but can't do it alone
Mar 16, 2023 11:12am